2015 annual financial data
Iovance Biotherapeutics 2015 Operating margin
Iovance Biotherapeutics 2015 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -27,860,000 USD and net income was -27,660,000 USD.
Operating cash flow was -18,381,000 USD.
Get free Iovance Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -27,860,000 USD
- Net income
- -27,660,000 USD
- Operating cash flow
- -18,381,000 USD